Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Drug-Induced Liver Injury from Elexacaftor/Ivacaftor/Tezacaftor

Drug-Induced Liver Injury from Elexacaftor/Ivacaftor/Tezacaftor

Resource Type

CF Research News

Authors

Sarah Lowry; Peter J. Mogayzel, Jr.; Kiyoko Oshima; Wikrom Karnsakul

References

J Cyst Fibros. 2021 Jul 16;S1569-1993(21)01297-2. doi: 10.1016/j.jcf.2021.07.001.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

CFTR modulator [3]
Drug-induced liver injury [4]

Date

Friday, July 16, 2021

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [5]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/drug-induced-liver-injury-elexacaftorivacaftortezacaftor

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-21-00193R2_FINAL_Lowry_070821.pdf [2] https://pubmed.ncbi.nlm.nih.gov/34275759/ [3] https://www.ecfs.eu/research-article-keywords/cftr-modulator [4] https://www.ecfs.eu/research-article-keywords/drug-induced-liver-injury [5] https://www.ecfs.eu/resource-guideline-type/other-guidelines